SI Stock Snapshot
Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
03
Price$19.01
Market Cap (MRQ)$396M
P/E (TTM)23.5
EPS (TTM)$0.81
Revenue (TTM)$60M
ROE (TTM)-151.9%
Debt/Equity (MRQ)0.1
52W Range$11–$25
SI Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance
Revenue, net income, margins and EPS trends
06
Revenue$47M2024-12-31 → 2025-12-31
EPS$-4.652024-12-31 → 2025-12-31
Free Cash Flow$-36M2025-12-31 → 2025-12-31
Net margin-58.3%2025-12-31 → 2025-12-31
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
SI
5Y avg
Peer Median
Verdict
P/E (TTM)
23.5
·
·
·
P/S (TTM)
6.6
·
5.0
Overvalued
P/B (MRQ)
3.2
·
3.5
Fair value
EV / EBITDA
-14.5
·
·
·
Price / FCF (TTM)
-8.4
·
·
·
Price / Cash Flow (TTM)
-10.7
·
·
·
EV / Revenue
8.1
·
·
·
EV / FCF
-10.6
·
·
·
Price / Tangible Book (MRQ)
3.2
·
·
·
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
SI
5Y avg
Peer Median
Verdict
Gross Margin (TTM)
77.3%
·
76.2%
Top tier
Operating Margin (TTM)
-58.5%
·
-40.4%
Weak
EBITDA Margin
-55.6%
·
-40.4%
Weak
Pretax Margin (TTM)
-58.3%
·
-39.0%
Below avg
Net Profit Margin (TTM)
-58.3%
·
-41.3%
Weak
ROA (TTM)
-30.5%
·
-31.2%
Weak
ROE (TTM)
-151.9%
·
-73.1%
Weak
ROIC
-16.9%
·
-26.2%
Top tier
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
SI
5Y avg
Peer Median
Verdict
Debt / Equity (MRQ)
0.1
·
0.6
Low debt
Current Ratio (MRQ)
10.7
·
4.8
Strong liquidity
Quick Ratio
2.5
·
3.3
Low liquidity
Long-Term Debt / Equity (MRQ)
0.1
·
0.6
Low debt
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
SI
5Y avg
Peer Median
Verdict
Revenue YoY
49.6%
·
·
·
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
SI
5Y avg
Peer Median
Verdict
EPS (Diluted)
$-4.65
·
·
·
Revenue / Share
$5.46
·
·
·
Cash Flow / Share
$-3.30
·
·
·
Cash / Share
$1.30
·
·
·
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
SI
5Y avg
Peer Median
Verdict
Asset Turnover
0.4
·
0.6
Weak
Inventory Turnover
0.6
·
2.1
Weak
Receivables Turnover
7.1
·
6.6
In line
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History
EPS actual vs estimate, surprise %, beat rate, next earnings date
14
Avg Surprise-3.8%
Next ReportNov 09, 2026
Period
Report
EPS Actual
EPS Est
Surprise
June 30, 2026
$-0.46
$-0.47
2.9%
March 31, 2026
May 13, 2026
$-0.41
$-0.42
3.1%
Dec. 31, 2025
$-0.38
$-0.33
-14.5%
Sept. 30, 2025
$-0.64
$-0.32
-101.8%
June 30, 2025
$-0.06
$-0.71
91.6%
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement16
Metric
Trend
2025
2024
Revenue
$47M
$32M
Cost of Revenue
$11M
$7M
Gross Profit
$36M
$24M
R&D Expense
$8M
$4M
SG&A Expense
$55M
$35M
Operating Income
$-26M
$-15M
Interest Income
$2M
$770.0K
Other Non-op
$-56.0K
$350.0K
Pretax Income
$-40M
$-16M
Income Tax
$0
$0
Net Income
$-40M
$-16M
EPS (Basic)
$-4.65
$-242.04
EPS (Diluted)
$-4.65
$-242.04
Shares (Basic)
8,673,148
64,530
Shares (Diluted)
8,673,148
64,530
EBITDA
$-26M
·
Balance Sheet25
Metric
Trend
2025
2024
Cash & Equivalents
$27M
$6M
Receivables
$8M
$5M
Inventory
$22M
$14M
Prepaid Expense
$2M
$431.0K
Other Current Assets
$1M
$573.0K
Current Assets
$157M
$35M
PP&E (Net)
$13M
$7M
PP&E (Gross)
$19M
$12M
Accum. Depreciation
$7M
$4M
Intangibles
$100.0K
$400.0K
Other Non-current Assets
$0
·
Total Assets
$170M
$43M
Accounts Payable
$9M
$5M
Accrued Liabilities
$5M
$3M
Current Liabilities
$14M
$8M
Other Non-current Liabilities
$51.0K
$25.0K
Total Liabilities
$29M
$23M
Total Debt
$15M
·
Common Stock
$21.0K
$1.0K
Paid-in Capital
$238M
$2M
Retained Earnings
$-97M
$-57M
AOCI
$117.0K
$197.0K
Stockholders' Equity
$141M
$-55M
Liabilities + Equity
$170M
$43M
Shares Outstanding
20,623,457
83,882
Cash Flow6
Metric
Trend
2025
2024
Stock-based Comp
$996.0K
$754.0K
Operating Cash Flow
$-29M
$-14M
CapEx
$7M
$4M
Investing Cash Flow
$-96M
$14M
Financing Cash Flow
$145M
$66.0K
Free Cash Flow
$-36M
·
Profitability8
Metric
Trend
2025
2024
Gross Margin
76.5%
·
Operating Margin
-55.6%
·
Net Margin
-85.3%
·
Pretax Margin
-85.3%
·
EBITDA Margin
-55.6%
·
ROA
-37.9%
·
ROE
-129.1%
·
ROIC
-16.9%
·
Liquidity & Solvency4
Metric
Trend
2025
2024
Current Ratio
11.1
·
Quick Ratio
2.5
·
Debt / Equity
0.1
·
LT Debt / Equity
0.1
·
Efficiency3
Metric
Trend
2025
2024
Asset Turnover
0.4
·
Inventory Turnover
0.6
·
Receivables Turnover
7.1
·
Per Share5
Metric
Trend
2025
2024
Book Value / Share
$6.82
·
Revenue / Share
$5.46
·
Cash Flow / Share
$-3.30
·
Cash / Share
$1.30
·
EPS (TTM)
$-4.65
·
Growth Rates1
Metric
Trend
2025
2024
Revenue YoY
49.6%
·
Valuation (TTM)14
Metric
Trend
2025
2024
Revenue TTM
$47M
·
Net Income TTM
$-40M
·
Market Cap
$295M
·
Enterprise Value
$283M
·
P/E
-3.1
·
P/S
6.2
·
P/B
2.1
·
P / Tangible Book
2.1
·
P / Cash Flow
-10.3
·
P / FCF
-8.2
·
EV / EBITDA
-10.8
·
EV / FCF
-7.9
·
EV / Revenue
6.0
·
Earnings Yield
-32.5%
·
Income Statement15
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Revenue
$17M
$17M
$14M
$12M
$11M
$10M
$9M
$7M
$8M
Cost of Revenue
$4M
$4M
$3M
$3M
$3M
$2M
$2M
$2M
$2M
Gross Profit
$13M
$13M
$11M
$9M
$8M
$8M
$7M
$6M
$6M
R&D Expense
$3M
$4M
$3M
$2M
$1M
$2M
$1M
$1M
$1M
SG&A Expense
$20M
$18M
$16M
$15M
$13M
$11M
$9M
$8M
$9M
Operating Income
$-10M
$-9M
$-8M
$-8M
$-6M
$-4M
$-4M
$-4M
$-4M
Other Non-op
$-201.0K
$161.0K
$137.0K
$1M
$-1M
$-1.0K
$135.0K
$142.0K
$100.0K
Pretax Income
$-10M
$-8M
$-8M
$-9M
$-19M
$-5M
$-4M
$-4M
$-4M
Income Tax
$0
$0
$0
$0
$0
$0
$0
$0
$0
Net Income
$-10M
$-8M
$-8M
$-9M
$-19M
$-5M
$-4M
$-4M
$-4M
EPS (Basic)
$-0.49
$-0.41
$2.35
$-0.64
$-165.53
$-52.13
$-38.23
$-68.31
$-72.74
EPS (Diluted)
$-0.49
$-0.41
$2.35
$-0.64
$-165.53
$-52.13
$-38.23
$-68.31
$-72.74
Shares (Basic)
20,735,694
20,653,035
·
13,604,556
115,965
89,438
·
59,372
57,354
Shares (Diluted)
20,735,694
20,653,035
·
13,604,556
115,965
89,438
·
59,372
57,354
EBITDA
$-10M
$-9M
·
$-8M
$-6M
·
·
·
·
Balance Sheet25
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Cash & Equivalents
$24M
$11M
$27M
$55M
$27M
·
$6M
·
·
Receivables
$11M
$11M
$8M
$7M
$7M
·
$5M
·
·
Inventory
$23M
$22M
$22M
$19M
$17M
·
$14M
·
·
Prepaid Expense
$2M
$2M
$2M
$2M
$691.0K
·
$431.0K
·
·
Other Current Assets
$2M
$3M
$1M
$1M
$5M
·
$573.0K
·
·
Current Assets
$137M
$146M
$157M
$167M
$69M
·
$35M
·
·
PP&E (Net)
$14M
$14M
$13M
$11M
$9M
·
$7M
·
·
PP&E (Gross)
·
·
$19M
·
·
·
$12M
·
·
Accum. Depreciation
·
·
$7M
·
·
·
$4M
·
·
Intangibles
$0
$25.0K
$100.0K
$175.0K
$250.0K
·
$400.0K
·
·
Other Non-current Assets
$33.0K
·
·
·
·
·
·
·
·
Total Assets
$152M
$160M
$170M
$178M
$78M
·
$43M
·
·
Accounts Payable
$6M
$6M
$9M
$9M
$6M
·
$5M
·
·
Accrued Liabilities
$7M
$6M
$5M
$6M
$6M
·
$3M
·
·
Current Liabilities
$13M
$12M
$14M
$15M
$12M
·
$8M
·
·
Other Non-current Liabilities
$34.0K
$43.0K
$51.0K
$63.0K
$84.0K
·
$25.0K
·
·
Total Liabilities
$28M
$27M
$29M
$30M
$29M
·
$23M
·
·
Total Debt
$15M
$15M
·
$15M
$15M
·
·
·
·
Common Stock
$21.0K
$21.0K
$21.0K
$21.0K
$1.0K
·
$1.0K
·
·
Paid-in Capital
$240M
$239M
$238M
$237M
$3M
·
$2M
·
·
Retained Earnings
$-116M
$-106M
$-97M
$-90M
$-81M
·
$-57M
·
·
AOCI
$-104.0K
$-64.0K
$117.0K
$39.0K
$82.0K
·
$197.0K
·
·
Stockholders' Equity
$124M
$133M
$141M
$148M
$-78M
·
$-55M
·
·
Liabilities + Equity
$152M
$160M
$170M
$178M
$78M
·
$43M
·
·
Shares Outstanding
20,822,472
20,703,159
20,623,457
20,584,787
2,839,173
·
83,882
·
·
Cash Flow6
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Stock-based Comp
$1M
$726.0K
$381.0K
$298.0K
$190.0K
$127.0K
$179.0K
$237.0K
·
Operating Cash Flow
$-7M
$-12M
$-9M
$-9M
$-5M
$-6M
$-3M
$-5M
·
CapEx
$2M
$3M
$2M
$3M
$1M
$843.0K
$1M
$887.0K
·
Investing Cash Flow
$20M
$-3M
$-17M
$-72M
$7M
$-13M
$4M
$5M
·
Financing Cash Flow
$-84.0K
$101.0K
$-2M
$109M
$18M
$20M
$0
$66.0K
·
Free Cash Flow
·
$-15M
·
·
·
·
·
·
·
Profitability8
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Gross Margin
78.3%
77.7%
·
76.2%
76.2%
·
·
·
·
Operating Margin
-58.4%
-53.7%
·
-65.0%
-53.2%
·
·
·
·
Net Margin
-59.1%
-50.1%
·
-74.2%
-174.3%
·
·
·
·
Pretax Margin
-59.1%
-50.1%
·
-74.2%
-174.3%
·
·
·
·
EBITDA Margin
-58.4%
-53.7%
·
-65.0%
-53.2%
·
·
·
·
ROA
-8.8%
-10.4%
·
-9.8%
-49.3%
·
·
·
·
ROE
-44.0%
-12.6%
·
-11.8%
49.1%
·
·
·
·
ROIC
-7.2%
-6.1%
·
-4.7%
9.2%
·
·
·
·
Liquidity & Solvency4
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Current Ratio
10.7
11.8
·
11.1
5.5
·
·
·
·
Quick Ratio
2.8
1.8
·
4.1
2.7
·
·
·
·
Debt / Equity
0.1
0.1
·
0.1
-0.2
·
·
·
·
LT Debt / Equity
0.1
0.1
·
0.1
-0.2
·
·
·
·
Efficiency3
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Asset Turnover
0.1
0.2
·
0.1
0.3
·
·
·
·
Inventory Turnover
0.2
0.3
·
0.3
0.3
·
·
·
·
Receivables Turnover
1.9
3.2
·
3.3
3.2
·
·
·
·
Per Share5
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Book Value / Share
$5.97
$6.42
·
$7.18
$-27.54
·
·
·
·
Revenue / Share
$0.83
$0.81
·
$0.86
$94.97
·
·
·
·
Cash Flow / Share
·
$-0.60
·
·
·
·
·
·
·
Cash / Share
$1.17
$0.56
·
$2.67
$9.53
·
·
·
·
EPS (TTM)
$0.81
$-164.23
·
$-256.53
$-324.20
$-231.41
·
·
·
Valuation (TTM)11
Metric
Trend
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Revenue TTM
$60M
$54M
·
$42M
$37M
$35M
·
·
·
Net Income TTM
$-35M
$-44M
·
$-36M
$-32M
$-17M
·
·
·
Market Cap
$422M
$301M
·
$258M
·
·
·
·
·
Enterprise Value
$413M
$304M
·
$218M
·
·
·
·
·
P/E
25.0
-0.1
·
-0.0
·
·
·
·
·
P/S
7.0
5.6
·
6.2
·
·
·
·
·
P/B
3.4
2.3
·
1.7
·
·
·
·
·
P / Tangible Book
3.4
2.3
·
1.7
·
·
·
·
·
P / Cash Flow
·
-24.3
·
·
·
·
·
·
·
EV / Revenue
6.9
5.6
·
5.2
·
·
·
·
·
Earnings Yield
4.0%
-1130.3%
·
-2044.1%
·
·
·
·
·
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2025-12-31
2024-12-31
Revenue
$47M
$32M
Gross Margin %
76.5%
·
Operating Margin %
-55.6%
·
Net Income
$-40M
$-16M
Diluted EPS
$-4.65
$-242.04
Metric
2025-12-31
2024-12-31
Debt / Equity
0.1
·
Current Ratio
11.1
·
Quick Ratio
2.5
·
Metric
2025-12-31
2024-12-31
Free Cash Flow
$-36M
·
Institutional owners (13F)
73 filers
· $170.8M total
· As of June 30, 2026
17
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders73
Value held$170.8M
New positions23
Exited positions9
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
23 (+7 vs prior Q)
9 (+2 vs prior Q)
30 (+6 vs prior Q)
10 (+1 vs prior Q)
+405K
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
Filer
Filed
Stake
Status
Purpose
Filing
Gilde Healthcare Holding B.V., Gilde Healthcare V Management B.V., Cooperatieve Gilde Healthcare V U.A., Manapouri B.V., Martemanshurk B.V.
×2 filings
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders
12 insiders
· 4 officers · 9 directors